全文获取类型
收费全文 | 11151篇 |
免费 | 567篇 |
国内免费 | 280篇 |
专业分类
耳鼻咽喉 | 35篇 |
儿科学 | 514篇 |
妇产科学 | 360篇 |
基础医学 | 926篇 |
口腔科学 | 44篇 |
临床医学 | 676篇 |
内科学 | 2717篇 |
皮肤病学 | 54篇 |
神经病学 | 448篇 |
特种医学 | 145篇 |
外科学 | 1573篇 |
综合类 | 876篇 |
预防医学 | 2624篇 |
眼科学 | 5篇 |
药学 | 477篇 |
4篇 | |
中国医学 | 323篇 |
肿瘤学 | 197篇 |
出版年
2024年 | 9篇 |
2023年 | 242篇 |
2022年 | 481篇 |
2021年 | 692篇 |
2020年 | 563篇 |
2019年 | 613篇 |
2018年 | 569篇 |
2017年 | 356篇 |
2016年 | 440篇 |
2015年 | 370篇 |
2014年 | 960篇 |
2013年 | 718篇 |
2012年 | 565篇 |
2011年 | 825篇 |
2010年 | 558篇 |
2009年 | 669篇 |
2008年 | 650篇 |
2007年 | 599篇 |
2006年 | 408篇 |
2005年 | 353篇 |
2004年 | 249篇 |
2003年 | 192篇 |
2002年 | 133篇 |
2001年 | 93篇 |
2000年 | 66篇 |
1999年 | 64篇 |
1998年 | 50篇 |
1997年 | 48篇 |
1996年 | 29篇 |
1995年 | 34篇 |
1994年 | 25篇 |
1993年 | 32篇 |
1992年 | 20篇 |
1991年 | 13篇 |
1990年 | 19篇 |
1989年 | 13篇 |
1988年 | 19篇 |
1987年 | 20篇 |
1986年 | 14篇 |
1985年 | 29篇 |
1984年 | 27篇 |
1983年 | 17篇 |
1982年 | 22篇 |
1981年 | 16篇 |
1980年 | 14篇 |
1979年 | 21篇 |
1978年 | 22篇 |
1977年 | 10篇 |
1973年 | 8篇 |
1967年 | 8篇 |
排序方式: 共有10000条查询结果,搜索用时 24 毫秒
31.
《Joint, bone, spine : revue du rhumatisme》2020,87(1):103-104
32.
《Taiwanese journal of obstetrics & gynecology》2020,59(1):34-38
ObjectiveTo determine the effect of obesity on the onset of spontaneous labor, scheduled delivery rates and perinatal outcomes in term pregnancies.Material and methods242 obese and 244 non-obese pregnant women ≥37 gestational weeks were compared in terms of the onset of spontaneous labor, scheduled delivery rates and perinatal outcomes.ResultsObese pregnant women had statistically significantly lower onset of spontaneous labor and higher rates of scheduled delivery. No difference was determined in respect of the type of delivery, 1st and 5th minutes APGAR scores and the need for intensive care. Higher values of birth weight, large for gestational age, macrosomia, gestational diabetes mellitus and preeclampsia were determined in obese women.ConclusionThe onset of spontaneous labor rates in term obese pregnancies were lower and scheduled delivery rates were higher than in the non-obese pregnancies. However, more extensive studies are needed to better understand this relationship. 相似文献
33.
34.
35.
《Surgery for obesity and related diseases》2022,18(6):762-771
BackgroundNew antidiabetic agents (sodium-glucose cotransporter-2 inhibitor [SGLT2i] and glucagon-like peptide-1 receptor agonist [GLP-1RA]) and metabolic surgery have protective effects on metabolic syndromes.ObjectivesTo compare the changes of metabolic parameters and costs among patients with obesity and type 2 diabetes undergoing metabolic surgery and initiating new antidiabetic agents over 12 months.SettingHong Kong Hospital Authority database from 2006–2017.MethodsThis is a population-wide retrospective cohort study consisting of 2616 patients (1810 SGLT2i, 528 GLP-1RA, 278 metabolic surgery). Inverse probability treatment weighting of propensity score was applied to balance baseline covariates of patients with obesity and type 2 diabetes who underwent metabolic surgery, or initiated SGLT2i or GLP-1RA. Metabolic parameters and direct medical costs were measured and compared from baseline to 12 months in metabolic surgery, SGLT2i, and GLP-1RA groups.ResultsPatients in all 3 groups had improved metabolic parameters over a 12-month period. Patients with metabolic surgery achieved significantly better outcomes in BMI (?5.39, ?.56, ?.40 kg/m2, P < .001), % total weight loss (15.16%, 1.34%, 1.63%, P < .001), systolic (?2.21, ?.59, 1.28 mm Hg, P < .001) and diastolic (?1.16, .50, ?.13 mm Hg, P < .001) blood pressure, HbA1c (?1.80%, ?.77%, ?.80%, P < .001), triglycerides (?.64, ?.11, ?.09 mmol/L, P < .001), and estimated glomerular filtration rate (3.08, ?1.37, ?.41 mL/min/1.73m2, P < .001) after 12 months compared with patients with SGLT2i and GLP1-RA. Although the metabolic surgery group incurred the greatest direct medical costs (US$33,551, US$10,945, US$10,627, P < .001), largely due to the surgery itself and related hospitalization, the total monthly direct medical expenditure of metabolic surgery group became lower than that of SGLT2i and GLP-1RA groups at 7 months.ConclusionBeneficial weight loss and metabolic outcomes at 12 months were observed in all 3 groups, among which the metabolic surgery group showed the most remarkable effects but incurred the greatest medical costs. However, studies with a longer follow-up period are warranted to show long-term outcomes. 相似文献
36.
37.
38.
39.
40.